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Behavior, plasma cAMP and brain cAMP level were studied in
normal and morphine-addicted rats and mice. Compared with nor¬
mals, significantly lower plasma cAMP level was observed in addicted
rats that are still on drug actions. On the other hand, signi¬
ficant higher plasma cAMP level was associated with naloxone-
precipitated withdrawal. The level of plasma cAMP correlated
with the severity of withdrawal. Brain cAMP level rose slightly
during naloxone-precipitated withdrawal in mice, but it was not
considered significant statistically.
AES suppressed the withdrawal symptoms significantly. In
addition it lowered the plasma cAMP level of naloxone-precipitated
withdrawing rats by 20% after treatment although the level of
statistical significance was not high (0.2p0.l). When PDE
inhibitors, IBMX or theophylline was administered to increase the
tissue cAMP level, the suppressive action of AES on withdrawal
symptoms was completely cancelled. Direct injection of DBoAMP
i
into the brain of addicted mice also antagonised the suppressive
action of AES on naloxone-precipitated withdrawal symptoms.
The results are compatible to the proposal that morphine
analgesia, tolerance and physical dependence are influenced
directly or indirectly by cAMP-modulated central processes. The
antagonism of AES's suppressive action on withdrawal by PDE
inhibitors and cAMP would suggest that one of the underlying
mechanism of AES may be associated with a cAMP-modulating system.
2INTRODUCTION
One of the world's serious and long-lasting social problems
is narcotic drug abuse. Narcotic opiate includes opium, drugs
derived from opium (such as morphine, heroin and codeine) and
drugs that shows cross tolerance to morphine. Opium has been
used as a drug since classical Greek time not only because it
reduces pain but also because it gives rise to euphoria. The
word opium from the Greek word opt on which means poppy juice.
The drug itself is obtained from the milky exudate after incision
.of the unripe seedpod of the poppy Papavev somniferwn. Morphine
is the most commonly abused narcotic drug and is the representative
drug in the study of narcotic addiction. These drugs are dangerously
addictive to man. In addicted persons they can produce a patholo¬
gical hunger which overrides all sense of responsibilities. Such
a profound alternation of human behavior is probably connected
with some important biochemical and physiological changes in the
body.
Before examining the biochemical basis of narcotic addiction,
we must first define drug tolerance and physical dependence. Drug
tolerance is a state of decreased responsiveness of the system to
a pharmacological action of the drug, resulting from prior exposure
of the system to that drug. It can be expressed quantitatively
as the median dosage required to produce a standardized response,
e.g. (Way et aZ. 1969). Physical dependence may be defined
as the state of latent hyperexcitability which develops following
prolonged exposure to drug. It can be manifested as specific
3symptoms and signs (the abstinence syndrome) upon abrupt termina-
tion of drug administration or by administering an antagonist.
The degree of dependence may be quantitized by the severity of
withdrawal syndrome or the median dose of pure antagonist required
to precipitate the withdrawal syndrome, e.g. ED (Way et at,,50
1969).
Tolerance and physical dependence on narcotics develop
simultaneously. The rate and degree of development are propor-
tional to the. dose and the frequency of administration. Tolerance
to some of the agonistic effects of morphine may persist for
months (Martin Jasinski, 1969). Physical dependence has also
been reported to degenerate with a half life of about 2 weeks (Brase,
et al.y 1976). Cross tolerance may develop to all narcotic
effects amongst all morphine-like analgesics (Eddy, 1955). Toler-
ance and physical dependence can also be expressed in vitro.
Hi us, cell cultures, brain slices, guines pig ileum and even a
single neurone (North Karras, 1978) have all been shown to
develop tolerance and physical dependence after prolong treatment
wiIh mo rnh i n e.
I Theories on the mechani sms of tolerance and physical dependence:
Theories related to tolerance and physical dependence are
generally postulated as a kind of counter-adaptation
to the agonistic action of the drug. Resulting from this counter-
adaptation, the development of latent hyperexcitability in
the central nervous system may be responsible for producing
abstinence syndrome when the drug is withdrawn abruptly. Such
4a hypothesis is suggested by the fact that the direction of
change in directly observable physiological variables, such as
respiratory rate, size of pupils, locomotory activities, pain
threshold etc., during the primary abstinence syndrome, is oppo-
site to that produced by the drug in the non-tolerant state.
The following sections summarize the major hypotheses con-
cerning the development of tolerance and physical dependence.
1.1. Biological disposition:
Early proposals on the mechanism of tolerance are based on
the differences between tolerant and non-tolerant animals in
terms of absorption, distribution, metabolism and excretion of
narcotic analgesics. However, with more data available, these
theories were not sufficient to account for the phenomena observed
(Way Adler, 1960).
1.2. Ilomeostatic theory:
In iBimmelsbach (1943) homeostatic theory, the counter-
adaptation is the autonomic adjustments to restore homeostasis in
response to the action of morphine. Abstinence is manifested when
the new equilibrium is unchecked upon the withdrawal of morphine.
1.3. Disuse hypersensitivity theory:
Jaffe and Sharpless1 theory (1968) proposes that hyperexci-
tability of postsynaptic elements to neurotransmitter can deve-
lop as a consequence of prolong disuse of the synapses through
continuous pharmacological blockage by morphine. Abstinence
syndrome arises as a result of the hyperactivity of the neural
5pathway.
1.4. Re dun da n t pa thway s:
Martin et ah. (1970) proposed that neural functional systems
are mediated by parallel pathways differing in their sensitivities
to chemical agents. One of the pathways is normally inactive, and
it is called redundant. When the active pathway is depressed by
morphine, the redundant pathway increases its functional role
(i.e. tolerance). Withdrawal of morphine unblocks the normal
pathway which together with the redundant pathway leads to exag-
gerated function of the system (abstinence syndrome). However,
direct experimental support to this hypothesis is lacking.
1.5. Receptor expansion theory:
Collier (1966) proposed that drug receptors may be in a
silent (i.e. receptor-drug interaction produces no pharmaco-
logical effect) or an active state (i.e. receptor-drug inter-
action produces an effect). By blocking a receptor from its
endogenous excitatory transmitter or by a reduction in the level
of the excitatory transmitter, excitation in the neural tissue
can be reduced. Counter-adaptation of this effect may induce new
active receptors from the transformation of silent receptors.
Thus normal excitation resumes (tolerance). After the drug is
withdrawn,disapperance of the surplus active receptors lags behind
the restoration of the transmitter or the disapperance of the
drug molecules from the cell, anu excess excitation results
(abstinence svndrome).
6The changes are in opposite directions when the transmitter
is inhibitory.
1.6. Enzyme expansion theory:
Based on the effects of a number of sedative drugs on enzymes,
Shuster (1961) and Goldstein Goldstein (1968) proposed the
metabolic theory of tolerance and physical dependence. In this
theory morphine may act at two levels: 1) by inhibiting the action
or synthesis of a neurohumoral transmitter whereby causing analgesia,
sedation and other morphine effects; and 2) by either de-repressing
the synthesis of the enzyme concerned with the synthesis of the
neurohumoral transmitter, or by repressing the synthesis of an
enzyme which destroys the neurohumoral transmitter (in response to
the 1st action). As a consequence of continuous administration of
morphine, the activity of the transmitter-synthesizing enzyme
steadily increases and thus reducing the primary effects of the
drug (tolerance). When morphine is withdrawn, both actions of the
drug cease. Because there is a great increase in neurohumoral
transmitter-synthesizing enzyme level, excess transmitters will
be synthesized. This upsurge of transmitter level may be respond
sible for the appearance of abstinence.
Administration of inhibitors of nucleic acid function or
protein synthesis can prevent the development of tolerance and
physical dependence on morphine and other narcotic drugs (Cox
Osman, 1970). This observation supports the hypothesis that the
development of tolerance and physical dependence depends on de
novo synthesis of protein in the nervous system; one of the
7requirements of the enzyme expansion theory and the receptor expan-
sion theory.
Although the theories presented above seem very different
from each other, they are not mutually exclusive. Indeed with
minor modifications, any one of them can be restated in such a way
as to fit the data of the others.
II.1. Adenosine 3',5'-monophosphate:
It is now well established that adenosine 3',5'-monophosphate
(cAMP) serves as an intracellular second messenger for the action
of a number of circulating hormones (Jose Rickenberg, 1971) and
putative neurotransmitters (Nathanson, 1977). Formed from adenosine
5'-triphosphate (ATP) by activation of membrane-bound enzyme adeny-
late cyclase, cAMP represents the first link in a chain of intra-
cellular biochemical reaction that ultimately results in the
physiological expression of the biochemical messenger action.
cAMP is degraded by phosphodiesterases which are activated by a
Ca bound protein activator (Uzunov, 1976). cAMP has been esta-
blished to exert influences on most of the fundamental physio-
logical processes which include muscle contraction, cell division,
endocrine functions and etc. The role of cAMP in neural function
has been recently reviewed by Nathanson (1977).
The mechanism of action of cAMP in modulating neural func-
tions may probably involve 1) the modulation of membrane ion
permeability, 2) the synthesis, transport and release of neuro-
transmitters and 3) the neurotubular functions (Greengard, 1976)
through the action of cAMP-dependent protein kinase, protein
8phosphatases and their substrates, and phosphodiesterase and its
activator, and is probably couple with the action of Ca and
sometimes cGMP (Rasmussen Goodman, 1977).
Adenylate cyclase is the sole source of cellular cAMP. It
is membrane bound and present in almost all cell types. Highest
concentration is found in neural tissues especially the synaptic
membrane. While phosphodiesterase is the only proven catalytic
enzyme for cAMP, passive extrusion of cAMP through -the plasma
membranee into extracellular medium were demonstrated in certain
tissue such as superfused sympathetic ganglia, incubated brain
slices and glioma cells. cAMP of central origin is transported
from CSF into the systemic circulation by an energy-dependent
process (Nathanson, 1977). Plasma cAMP and cGMP appeared to be
in a dynamic steady state and distributed in a space significantly
greater than the extracellular fluid volume. Exogenous adminis¬
tration of cyclic nucleotides showed that they are rapidly cleared
from plasma principally by extrarenal processes possibly involving
hepatic metabolism and biliary excretion. Little is known of the
origin of the plasma cyclic nucleotides-under basal conditions.
It is apparent that the cyclic nucleotides escape from or are
extruded by a wide variety of mamalian cell types. Blood cells
are not important sources in man. Monoamines, such as£-
adrenergic agonists, and hormones, such as ACTH, calcitonin,
gluagon, produce a slight increase in plasma and urinary cyclic
AMP (Broadus et at. 1971). Because of the large cyclic nucleotide
pool, it is expected that plasma level of the cyclic nucleotides
is a relatively insensitive index of small changes in the metabolism
9of these compounds in their respective miscible compartments.
Thus regional tissue levels are much more informative.
Xanthines such as 1,3,7-trimethylxanthine (caffeine), 1,3-
dimethylxanthine (theophylline) and 3-butyl-l-methylxanthine
(IBMX) are chemical analogue., of purines. They inhibit PDE activity
and the potency rank is IBMX, theophylline and caffeine. IBMX
was shown to be ten times more potent than theophylline in inhi¬
biting PDE activity in brain homogenate (Francis, et at1975).
By inhibition of PDE, the effect of certain cAMP-mediated processes
can be augmented and prolonged (Nathanson, 1977).
II.1.1. Effect of cAMP on morphine analgesia
When cAMP was administered to animals by peripheral injection,
analgesia induced by acute morphine injection was antagonized
(Ho et at. 1972). Pretreatment of adenine, adenosine and ATP
which stimulate cAMP formation, also decrease the acute effects of
morphine.
Xanthines, the potent PDE inhibitors, generally acentuate
nociception, stimulate respiration and produce irritability
to external stimuli. They also produce restlessness, wakefulness,
alertness, diarrhea, diuresis and tremor. Most of these effects
are the opposite of agonist action of morphine such as analgesia,
respiratory depression, drownsiness and constipation (Collier et
at. s 1976). Indeed, respiratory depression was shown to be
antagonized by caffeine (trimethy1-xanthine) and theophylline
(dimethyl-xanthine).
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II.1.2. Effect of cAMP on physical dependence
Peripheral administration of cAMP increased the withdrawal
symptoms of addicted animals (Ho et 'al. 19 72). Intracerebro-
ventricular injection of cAMP or DBcAMP had the same effect in
rats. However,with DBcGMP, Collier Francis (1975) found that
two withdrawal signs were lessened and no other symptom was
intensified. The relative potency of IBMX to caffeine in
reversing morphine inhibition of the isolated guinea pig ileum
is close to that inhibiting cAMP, but not cGMP hydrolysis, in
rat brain homogenate (Collier, 1977). He concluded that only
increase in cAMP was important and increase in cGMP was less or
not important in opiate abstinence. They also found that the
total withdrawal score by counting abstinence symptoms during
the first 15 min of naloxone-induced withdrawal was increased
by PDE inhibitors and reduced by PDE stimulant, e.g. imidazole.
Pretreatment with cAMP or PDE inhibitors also accelerated the
development of morphine tolerance and physical dependence.
In naive rat, injection of IBMX (a very potent PDE inhibitor)
and theophylline, would elicited an abstinence-like responses
in rat that was very similar to the precipitated abstinence
syndrome of morphine dependent rats. The effect is intensified
by injection of a small dose of naloxone. Naloxone alone had no
effect (Collier et al., 1974; Francis et at., 1975). The response
was called quasimorphine abstinence syndrome (QMAS) to distinguish
from the true morphine abstinence syndrome (TMAS). QMAS can be
suppressed by heroin potently (30 ygKg is significantly effec¬
tive) and in a dose-dependent manner. The suppression by heroin
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was antagonized by naloxone. It is not likely that the resemblance
between the QMAS and the TMAS is only coincidental since xanthine
also intensified the TMAS. A subcutaneous dose of 10 mgKg IBMX,
following by 1 mgKg naloxone produced a QMAS that was indis-
tinguished from the TMAS (Collier et al.y 1976). Summing up,
the combined action of naloxone and IBMX are almost completely
adequate to reproduce the state of opiate abstinence in non-addicted
rats.
II.1.3. cAMP level and AC activity during morphine addiction and
withdrawal
Despite evidences favoring the involvement of cAMP in
morphine addiction and withdrawal, reports on the changes in cAMP
level and AC activity after administration of morphine lack a
discernible pattern. (Table I II). Glouet 6c Iwatsubo (1976)
in their review on opiates and AC said that cAMP is both ubiquitous
(present everywhere) and epemeral (transient changes), so that
its levels in the whole tissue might be expected to fluctuate widely.
The other reasons may concern the method of fixation and assay
of cAMP since cAMP level rises rapidly immediately after death
and falls rapidly within a few minutes afterwards (Lust 6c Passonneau
1973).
II.1.4. Models from cell cultures studies
Less complicated results were obtained from the studies on
nerve cell cultures. In cultured neuroblastoma x glioma cells
which are rich in opiate receptors, both opiate and enkephalins
were found to inhibit PGE- and adenosine-stimulated cAMP
12
Table I. Oplates and brain adenylate cyelase activity.
Tissue Effeet Reference
A. Oplates administered to animals
Rat striatal
homogenate
Basal AC increased 1 hr
after morphine in dose-
dependent way
AC unaltered after acute
administration of morphine,
but decreased in withdrawal
Ruri at all., 1975












AC increased I he after
morphine
AC decreased after morphine
Chou at ab., 19 71
AC increase after chronic
morphine
Basal AC and DA-sensitivc
AC increase 15 mln after
morphine
Basal AC no change but
sensitive AC increased ir
Me rial ct al. 3 1975
Clouet Iwatsubo
19 76














MBasal AC activated at 10
morphine
PCR-stimula ted AC inhibito
bv 10 M morphine
-4
Basal AC activated by 10
morphine
Basal AC at 10 morphine
Chou c t al., 1971
Collier and Roy, 1974




A C = adenylate eyelase activity
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Table II. Opiates and Brain cAMP levels
Tissue Effect Reference
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formation by inhibiting adenylate cyclase (Sharma et al 1975a,
1975b). The inhibition was antagonize by naloxone. The potency
of inhibition by various opiates corresponded to the potency of
their receptors affinity and dextrophan is inactive. The parent
cell line, neuroblastoma, which has fewer morphine receptors is
slightly sensitive to morphine whereas the glioma parent which lacks
these receptor is insensitive. Sharma et at, (1975a) found an
increase in basal and PGE-sensitive AC activity in cells treated
chronically with morphine. This increase was antagonized by
naloxone. On withdrawal of morphine from the cell medium, the
AC activity decrease gradually and reached the normal level in
about 24 hours. Based on this finding Sharma et at.(1975b)
proposed a dual regulatory mechanism for AC to account for the
development of tolerance and dependence. The mechanism is
identical to the enzyme expansion theory described in section
1.6 except that the enzyme involved is a cAMP-synthesizing enzyme
instead of a transmitter metabolizing enzyme (Fig. 1).
II.2. Effect of neurotransmitters
It is well known that a number of transmitter systems
play an important role in the action of psychoactive drugs. Attempts
have been made to link changes at the tissue level with morphine
analgesia and the development of tolerance and physical dependence.
Most of the putative transmitters including ACh, catecholamines,
serotonin, histamine and GABA have been implicated by various groups
of workers. The intimate relationship of these transmitters with































Fig. 1. A model of the role of adenylate cyclase regulation in the develop-
ment of morphine tolerance and dependence: Modified from Sharma et
at. (19 75b) A, effects of morphine upon cAMP levels, and B, effects
of the opiate upon adenylate cyclase activity as a function of time.
Thus in this model morphine lowers cAMP level in nerve cells by
inhibition of the adenylate cyclase activity. The adenylate cyclase
content increases due to counter-adaptation. Thus tolerance and
dependence are built up and the cells resume normal cAMP level. Upon
withdrawal the latent hyperactivity of AC is unchecked and results
in very high cAMP level (abstinence). The AC content declines during
the recovery period. The cells are completely relieved form tolerance
and dependence when the AC content returns to normal level.
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presence of neuro-transmitter- specific adenylate cyclase
in the nervous tissues, particularly in the synaptic membrane
and by that the physiological receptors for certain neurotrans-
mitters may be identical to or closely associated with the regu-
latory subunit of the adenylate cyclase molecules (Nathanson 1977).
Recently the actions of these neurotransmitters in inducing
neurotransmissions were shown to be mediated or modulated by the
action of cyclic nucleotides and calcium ions (Rasmussen
Goodman, 1977). Thus changes in certain neurotransmitters levels
and the changes of cAMP levels should appear to be closely related.
So far none of the changes in transmitter levels can be
assigned a fundamental role or give satisfactory explanation to
the development of tolerance and physical dependence. Published
reports have been frequently contradictory and it is not certain
in any case that the change observed is not merely coincidental
or secondary to the fundamental mechanisms. Nevertheless it is
evident that the analgesic effect and individual abstinence signs
and symptoms are related to one transmitter or another (Table Ilia
b).
II. 3. Neurollormones
Many peptide hormones released in or from the brain have
been shown to exert their actions through activiation of a cyclic
nucleotide sensitive system. Specific hormone-sensitive adenylate
cyclases have been demonstrated. In the anterior pituitary gland
and the pineal gland, the hypothalamic polypeptide releasing factors
such as TRII, LRU, somatostatin, alter AC activity to effect or
17
Table Ilia. Summary of role of neurotransmitter in morphine analgesia tolerance
Neurotransmitter Relation to cAMP
ACh-sensitive AC in neuroblastic
cells. An increase in cCMP with
a concomitant decrease in cAMP
occurs in the muscarinic action
of ACh (Nathanson, 1977)
Catechol amines Munoaminergic path is believed to
be moderated by cAMP NE-
sensitive AC in cortex cere-
bellum. (Nathanson, 1977)
DA-sensitive AC is demonstrated
in cortex limbic system, espe-
cially striatum. DA- L NE-sensi-
tive AC are inhibited by opiates
N opiate peptides (Motomatsu et al
1977; Tsang et ai.t 1978).
5-HT-sensitive AC is found in






in many regions (Nathanson,
1977)
Stimulate AC activity in brain
(Wellimann ct al.3 1973) and
in nerve cell culture (Sharma
et a I., 1975)
Changes after acute dose of
Morphine 6. in tolerant animal
Increase in striatum after a
large dose of morphine or nalo-
xone. Effect diminishes in
tolerant animal (Way Bhargava,
1976)
Inconsistent results reported.
NE, DA altered biphasically in
striatum (Clouret Iwatsubo,
1975) or DA increased to 2 hr
and NE fluctuated (Wajda
Manigault, 1976). All agree with
an increase in tyrosine hydroxy-
lase, a rate determinating enzyme
of catecholamine synthesis.
Brain 5-HT remains unchanged but
turn-over rate increases. (Way,
1971)
Unchanged, however decrease in
hypothalamus after chronic morphine
treatment. (Henwood et at., 1975)
Opiate inhibit PCE-stimulate cAMP
formation in brain iiomogenate
(Collier et al.s 1974) and in
nerve cell culture. (Sharma et




Modest enhance with elevation of
ACh. Slight decrease with ACh
antagonists. Results are often
inconsistent (Way Bhargava,
1976)
Antagonized by depletion of brain
catecholamines with 111 inhibitors
(Verri, et a., 1967). Enhanced
by elevation of catecholamine by
MAO inhibitors (Eidelberg
Schwartz, 1970).
Antagonized by inhibiting 5-HT
synthesis with parachloropheny-
lamine (Way, 1971).
Liberate in brain in response to
noxious stimulation. Injection
of PCE into brain cause head ache
which is relieved by PG-synthesing
inhibitor, indomethacin. Indo-
methacin potentiate morphine
analgesia. (Collier et al. 3 1975)


















seem to be unnecessary when direct negotiations are effective.
On the other hand, high union membership proportion in utilities
and communication is attributable to several reasons. These companies
have quasi-monopolistic product markets and a high requirement for
skilled labour whose mobility is relatively lower owing to the lack
of other comparable companies to accommodate them. A predominantly
male labour force has a vested interest in improving long-term wages
and working conditions while the management have also done much to
commit the workers.
Fragmentation of Trade Unions
There are too many trade unions in Hong Kong and too many small
ones. Table 20 shows that 56.9 percent of the unions are small in
size and have a declared membership of not more than 250.
TABLE 20


































Source: Data derived from the figures in Registrar of Trade
Unions, Annual Report 1978-79 and 1979-80.
The most obvious source of divisiveness of unions is due to
political affiliation to either Communist or Nationalist alliances
and those who declare to be politically independent. Table 21 shows
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inhibit the release of the trophic hormones (Clouret Iwatsubo,
1976; Tsang Martin, 1976). Many of these peptide hromones may
have, in addition to action at specific targei tissues, a direct
effect on nerve transmission (Table IV). Some peptides (ACTH,
substance P, angiotensin and bradykinin) have been shown to
increase the frequency or amplitude of firing in the spinal cord
or brain, while other peptides (TRH, LRH, somatostatin and
vasopressin) have been shown to decrease neuronal firing. The
possible role of cyclic nucleotides in mediating the effect of
peptides on neuronal firing has not been investigated yet.
The administration of opiates has important effects on
hypothalamic pituitary peptides and nerve transmission. The
subject will be discussed by my collaborator. The possible role
of ACTH and TSH in morphine addiction and AES suppression of
morphine abstinence syndromes is under investigations in our
laboratory.









Increase in spontaneous firing in
spinal cord




Increase in spiking frequency in
superoptic nucleus
Increase in firing in spinal cord
Increase in firing in spinal cord
Increase in firing rate in frog
spinal motorneuroris





Sawyer et a I., 1968
Takahashi et al., 1974;
Phillis and Limacher, 1974;
Krnjevic et al., 1974
Marks et al., 1 974
Krivoy et al., 1 963
Krivoy et al., 1 974
Konishi and Otsuka, 1974
Renaud et al., 1975
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11,4. Opiate peptides
Recently a number of peptides having opiate activity were
isolated from mammalian brain tissues (Hughes, 1975; Li Chung,
1976). They are the pentapeptides leu- and met-enkephalins,
located mainly in the striatum, hypothalamus, central gray, and
amygdala which are also rich in opiate receptors. 'The larger
opiate peptides the a, 3 and y eridorphine are located mainly
in the pituitary gland (Loh Law, 1977). Their physiological
role is largely unknown. Frederickson (1977) suggests a systemic
hormonal role for the long-lasting ft-endorphinc and a central
transmitter role for the enkephalins. In many respects their
actions are similar to morphine. Morphine and enkephalins depressed
neuronal firing in the regions with high opiate receptors
(Frederickson, 1977). They also inhibit adenylate cyclase activity
and induce accumulation of cGMP, which are antagonised by nalo¬
xone, in the neuroblastoma x glioma hybrid cells and in slices
of rat neostriatum (Minneman Iversen, 1976). In addition, these
peptides also inhibit DA~ and NE-s t:i mul a ted formation of c AMP
in brain (Motomatsu et a'l., 19 7 7; Tsang et at., 19 78). Hence they may
modulate neurofunctions through their action in the cAMP system
(Greengard, 1976). Intravenous or i.e. administration of endorphins
can produce analgesia and pronounce behavioral changes similar to
morphine. Chronic administration of the peptides leads to the
development of tolerance and physical dependence. They show cross
tolerance to morphine and prevent naloxone-precipitated withdrawal
in morphine addicted naimals (Tsang et al1977). Based on the
above data it is apparent, that the opiate peptides exert their
21
effect by a similar if not identical mechanism to that of morphine.
Ill.1.Treatment of Narcotic Addiction
The treatment of drug addiction varies in three approaches.
They are cold turkey, maintenance and detoxification. The usual
method of detoxification is by giving methadone, a long-lasting
narcotic, in decreasing doses until the patient is completely
weaned of the drug. Inevitably some patients cannot be weaned
off and have to give a maintenance dose of methadone for variable
periods ranging up to years. Recently replacement by endorphine,
an endogenous long-acting opiate peptide, was successfully applied
in Taixan. In 1973, Wen and Cheung (1973a 1973b) reported that
acupuncture with electrical stimulation (AES) can alleviate with¬
drawal symptoms of human addicts. Usually 30 to 40 min of AES
is enough to relieve withdrawal symptoms completely. Since then,
over 500 cases of addiction treated by this method have been
carried out. In general, the AES treatment programme requires 7
days for complete detoxification. Some addicts were given methadone
for 3 days starting with 30 mg on the first day, then 20 10 mg
on the second and third day. Thereafter the addicts received only
a 30-min AES treatment two or three times a day for the rest of
the period. At the encl of the 7-day treatment they were sent to
a rehabilitation centre for mental and social rehabiliation. No
further treatment is required. The successful rate of this treat¬
ment technique is much higher compared with the methadone detoxi¬
fication method (Wen Teo, 1975).
Recently a fast detoxification method was developed by Wen
22
(1977) using AES combined with naloxone. This new technique
requires only 3 hours for complete detoxification.
III.2. Acupuncture
Acupuncture is an ancient medical technique which has been
practised in China for several thousand years. Its application
is quite versatile however its mechanism of action is still
unclear. The most well studied aspect is its analgesic effect.
Mayer et al.y (1977) and a number of investigators (Omura, 1976;
Marxs 1977) have hypothesized that acupuncture can release mor¬
phine-like substances which will act on the CNS to produce anal¬
gesia. They showed that acupuncture needling of Hoku point
increased the pain threshold. The analgesic effect took some time
to reach a maximum and outlasted the period of acupuncture needling.
Furthermore it can be completely reversed by naloxone injection.
Cross-transfusion of blood from an animal receiving analgesia can
increase the pain threshold of the partner with no acupuncture treatment
( 1974). These findings strongly imply the involvement of a
stable humoral factor in acupuncture analgesia. Further support
comes from the studies of Mayer and his associates (Mayer Price,
1976). They found that electrical stimulation of the brain stem
structures can inhibit a wide spectrum of noxious stimuli. They
considered such stimulation-produced analgesia (SPA) is analogous
to acupuncture analgesia. Tolerance to SPA and cross-tolerance
of SPA to morphine have been shown. SPA is antagonised by naloxone,
a opiate antagonist (Akil et a~l.y 1976). Like morphine analgesia
SPA can also be modified by monoaminergic agonist and antagonists
中
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(Akil Liebeskind, 1975). These results suggested a common under-
lying neural mechanism between SPA and morphine analgesia.
The sites for SPA correspond to the active sites of morphine
analgesia closely, viz., the periaqueductal and periventricular
grays and the medulla raphe nueleus. Because of the complexities
of these structures quite a complicated circuitry may be involved
in the system responsible for analgesia. The structures may receive
neural input form various brain regions which can modulate the
activity of the system for analgesia. They may be the focal point
for the system for analgesia which can be called into play by
elctrical stimulation or the administration of opiates (Mayer
Price, 1976).
On the other hand, Omura (1976) had compared the known acu-
puncture effects and the effects of morphine. He concluded that
the significant common effects are: analgesia, euphoria and
sedative effect. Other effects may be similar but while the
pharmacological effects of morphine is fixed, the acupuncture
effects depend on the conditions of the subject. Thus for the
hypotensive effect, morphine lowers blood pressure; acupuncture at
Stomach 36 lowers blood pressure in the majority of subjects
with normal or hypertension, but raises it towards normal in the
case of hypotension. With diarrhea morphine stops it through
reduction of perstalsis and cause constipation in normal subjects.
Acupuncture stops both diarrhea and constipation through regula-
tion of the intestestinal movements. Furthermore while respiratory
depression, nausea and vomiting are induced by morphine they
rarely occur in acupuncture. While morphine is a generalized
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analgesic, acupuncture analgesia can produce specific antinoci-
ceptive effect in restricted peripheral areas.
In view of these results the release of a morphine like
substance cannot account for all the effects of acupuncture anal-
gesia or acupuncture effects in general, especially its regulatory
properties on many physiological functional systems (01Connor
Bansky 1975). Whether in addition to a morphine-like substance,
other compounds are involved is still uncertain. A number of
likely candidates such as fragments of ACTH, and putative
neurotransmitters and hormones may fulfill this role.
The neural basis of transient effects of acupuncture analgesia
was studies by Chan and Fung (1975). They showed that when trains
of electrical biphasic pulses were delivered to the tsusanli
point in the hindlimb of the cat, a total suppression of cutaneous
polysynaptic reflex was produced. They suggested that acupuncture
analgesia can at least in part, be accounted for by a presynaptic
inhibitory mechanism in the spinal cord. Ikezono et at,3 (1976)
investigated the effect of acupuncture in changing the neuronal
activity of the perpheral and central nervous system and concluded
that acupuncture acts by reducing the excitability of specific
sensory pathways.
IV Clinical Observations
In view of the regulatory effect of acupuncture and capability
of AES in relieving withdrawal symptoms, research on the effect of
AES on physiological disturbances caused by addiction and withdrawal
has been investigated. The plasma ACTH, Cortisol, aldosterone,
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thyroxine, cAMP and cholesterol levels of chronic morphine addicts
and normal controls were examined. Compared with the normal
group, significant lower mean values of plasma ACTH, cholesterol
and cAMP and a higher thyroxine levels were found in the addicted
group. The plasma ACTH, Cortisol and cAMP rised during withdrawal
(Ho et al.3 1977; Wen et al,3 1978a).
During the 7 day AES-treatment program, both plasma ACTH and
Cortisol were observed to decrease after 30 min of AES treatment.
Lesser or no significant change in the hormonal levels were
observed on day 7 and day 10 when the patient were completely
relieved of withdrawal. The plasma cAMP was slightly lowered after
AES but it is not considered significant statistically.
In the fast detoxification program, AES is used in combination
with naloxone. Compared with the levels before naloxone injection.
Significant increase in plasma ACTH (130%), Cortisol (83%) levels
were observed. Plasma cAMP level showed a 24% increase but it is
not in statistical significance. Only mild withdrawal symptoms
were observed the patients could readily bear them (Wen, et a7._,19 78b:
Wong, 1977). It is suspected that the increase of plasma ACTH,
Cortisol and cAMP would have been even higher and withdrawal symptom
more severe if AES has not applied 30 min prior to the naloxone
iniections.
V. Aims and Objects
To support the clinical observations, experiments on laboratory
animals were carried out in collaboration with my colleague, Mr.
Y.F. Tsang. Rats and mice were used for the study. Behavioral
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and biochemical changes were monitored during addiction, withdrawal
and AES treatment. Our aim is to find out how AES works in the
treatment of drug addiction at the biochemical level.
The research consists of two parts. One part which concerns
changes of cAMP levels is investigated by me and the other which
deals with changes of ACTH and corticosterone is investigated by




Female mice of WHT strain (British) weighing 25 to 30 gm
and female rats of Sprague-Dawley strain weighing 200 to 250 gm
were used throughout the experiment. They were kept in a tem¬
perature and humidity controlled room with 12 hr light (6:00-18:00)
and 12 hr dark. Food and water were given ad libitum.
All reagents used were of reagent grade. Morphine IlCl was
obtained in powder from form May and Baker Ltd. (Dagenliam, U.K.).
Naloxone HC1 was a gift from Endo Laboratory Inc.,N.Y. Competitive
protein binding assay kit for cAMP was purchased from Radiochemical
Centre, (Amersham, Bucks, U.K.). Theophylline and isobutyl-
methyl xanthine were from Sigma Chemical Company (St. Louis, U.S.A.).
II. Extraction and assay procedure of plasma cAlP and brain cAl P and protein
A schematic outline of the procedures used is shown in
Fig. 2 3. The sensitivity of the cAMP assay kit was in the
range of 0.1 to 16 pmolincubation tube (or 4-320 pmolml of
extract). A linear standard curve was constructed for each batch
of unknown by plotting C C aganist the concentration of cyclic
o x
AMP (pmolincubation tube). C was the radioactivity bound in
the absence of unlabelled cyclic-AMP and C the radioactivity
bound in the presence of samples or standards. The precision and
accuracy of this kit were evaluated by four independent determina¬
tions of a standard containing 22.57 pmol cyclic AMPml. Based on
the results obtained, the percentage error was found to be 2.4%,
at 95% confidence level, and the accuracy was 86.4% (n=4).
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Sample (1 ml or 0.5 ml plasma)
Add 2 volumes of full ethanol
ppt.
wash with 1 vol.




Dry in a stream of N at 55°C
Redissolve in buffer
Aliquots for CBP assay
Add radioactive cAMP and binding protein
incubate for 2 hr at 4°C
Add dextran-charcoal at 4°C and
centrifuge immediately
Count bound radioactivities (Supernatant)
by a Beckman LS 330 liquid scintillation
counter
Fig. 2. Protocol for plasma cAMP determination
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Immerse mouse head in liquid nitrogen
immediately after decapitation for 30 to AO sec
Thaw in freezer (-10°C) for 2 to 4 hr and
then in refrigerator (0°C) for 1 hr
Cut the head into two halves on ice and
take out the brain totally while it is
still frozen and hard
Immerse in 2 ml 0.05 M tris buffer containing
4 mM EDTA pH 7.5
Homogenize in teflon homogenizer
Wash with 2 ml buffer and combine with the homogenate
Boil in boiling water bath for 5 min
Cool in ice bath
Centrifuge at 3,000 g
Add 4 ml 2 M NaOII to the remain




Determine the protein content
by the Iblin Lowry Method
Fig. 3. Protocol for extraction of brain cAMP
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Aliquots of 0.25 ml of samples and
BSA standard solutions diluted to
appropriate concentrations (0.05 to
0.2 mg/ml)
Add 0.25 ml 1% DOC solution
Add 2.5 ml freshly prepared Reagent A
Stand for 10 min at room temp.
Add 0.25 ml Folin Reagent (1:1 diluted)
Stand for 30 min at room temp
Read absorbance at 750 nm by
9 S QriPPfrnnTintriTTiPfpr
Reagent A: (a) 0.1 N NaOH+ NaOH+ 2% Na CO
(b) 1% CuSO.
(c) 2% Na K Tartrate
Mix solution (a), (b) (c) in 50: 1: 1 proportion
Fig. 4. Protocol for protein determination
by the method of Folin and Lowry (1951
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Protocol for brain protein determination was shown in Fig. 4.
Brain protein was first treated in 1 M NaOH to saponify the lipids.
1% DOC was added to ensure complete dissolution of the samples.
III. Statistical analysis
In the present study, data were pooled and presented as the
mean plus or minus one standard error of the mean. Values
lying outside the sensitivity range of the assay methods were
excluded. The Student's t-test was used to evaluate the signifi-
cance of the differences in the biochemical levels and the behavioral
scores tested. Except in borderline situations, p0.05 was
considered to be significant.
IV. Addiction
The animals were rendered dependent on morphine by either one
of the two methods:
IV.1. Injection method (for rats only):
Morphine-HCl was dissolved in sterile saline at
appropriate concentrations for intraperitoneal injections
in increasing dosage following either a 8-week schedule
or a 2-week schedule.
i) 8-week schedule: Rats were injected twice daily at
8:00 and 20:00. The beginning dosage was 5 mgKg
body weightinjection. The dosage was increased at
5 mg increment each day until a final dose of 40 mgKg.
It was then maintained for a total addiction period of
eight weeks (Mehta et al., 1975).
32
ii) 2-week schedule: Rats were injected twice a day at
9:00 and 17:00, with an increasing dose at 5.0, 10.0,
20.0 40.0 mgKg for the first, second, third and
fourth day, respectively. Thereafter the dosage was
maintained at 40 mgKg for a total period of two
weeks.
IV. 2. Morphine pellet implantation method (for mice only):
The morphine pellets were prepared and implanted
essentially according to Hui and Roberts (1975). The
pellets were made from molecular sieve Type 4A (Aluminium
sodium silicate, 18 inch in diameter and 7 mm in length).
They were washed with distilled water and dried at 110°
for 3 hours. After immersion in morphine-HCl solution
(2 gml) at 110° for 15 min, the pellets were removed,
blotted on filter paper thoroughly and then dried at
110° for 3 hours. The amount of morphine absorbed was
determined by measuring the absorbance at 250 nm in 0.1 M
sodium hydroxide. Each pellet contains approximately 15
mg morphine. Implantation was. carried out at 9:00. Each
mouse was anaesthesized with ether before the insertion
of pellets underneath the skin of its back.
V. Acupuncture with electrical stimulation (AES) treatment
Acupuncture with electrical sitmulation (AES) was performed
by inserting two 34 G acupuncture needles through the middle of
the conchae corresponding to the lung point of the human ear. The
lung point of human ear corresponds to a region, approximately
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3 mm wide circumscribing the centre of the deepest portion of
the cavum conchae (Wen Cheung, 1973a). The needles were
anchored into place by rubber fasteners. They were then connected
to a flexible electrical wire behind the back of the animal.
The current for stimulation was derived from a biphasic pulse
generator (Biopulse Ltd. Hong Kong). The frequency used was 125
Hz and the average voltage was 0.5 to 4 volts. Under such conditions,





Addicted rats were injected with naloxone intraperitoneally,
14 hours after the last morphine injection. They were placed in
transparent plastic cages (0.3 x 0.3 x 0.3 m) on a bench table.
Withdrawal symptoms were observed. Based on the work of Wei
et al.3 (1972) and Ng et al.3 (1975), five symptoms and signs
were chosen for our quantitative assay of physical dependence.
These include 1) wet dog shake (brief episodes of rapid
repetitive shaking of the entire trunk), 2) abnormal posturing
(mainly constriction and elongation of the abdomin), 3) teeth
chattering, 4) diarrhea, and 5) attempt to escape. Other signs
such as ptosis, licking anus, rearing, irritability to touch,
restless were also noted, but they were not generally used for
results. The frequency of occurence of each signs was counted and
recorded on standard score sheets. When a sign lasted for more
than 15 sec, another score was given. Normal rats injected with
naloxone in doses up to 1.0 mg did not show any sign of withdrawal.
I.1. Effect of AES on the time course of appearance of withdrawal
syndrome
I.1.1. Method
Nine rats were rendered dependent on morphine according to
the 8-week schedule. Thirteen hours after the last morphine
injection, the number of wet-dog shake was counted for 15 min
every 2 hx f or two days. Each rat was observed by the same person
throughout the entire period in order to minimize possible differences
See appendix
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due to judgement. At the same time, three addicted rats were
treated with AES thirteen hours after the last morphine injection
and observed in the same manner.
1.1.2. Results
The peak of withdrawal symptoms appeared between the 14th to
26th hour after the last injection of morphine (Fig. 5). Beyond
the 26th hour, it began to decline gradually. In view of this
observation, all the subsequent experiments designed to study
natural withdrawal were performed in the morning 14 to 17 hr after
the last morphine injection.
The pattern of withdrawal appearance on the AES treated rats
was very similar to that of the non-AES treated except the ampli-
tude of withdrawal scores were somewhat lesser (Fig. 5).
1.2. Effect of AES on naloxone-precipitated withdrawal syndrome
1.2.1. Method
Ten addicted rats (8-week schedule) were observed for 60 min,
14 hr after the last injection of morphine (scores were recorded
at every 5 min interval). At the end of this observation period,
0.2 mg naloxone was administered intraperitoneally and the behavior
was observed for another 30 min.
To test whether AES has an effect on natural and naloxone-
precipitated withdrawal. The following experiment was performed.
Addicted rats were first observed for 30 min, 14 hours after the
last injection of morphine. Then AES was applied and the frequency
of withdrawal scored. After 30 min, 0.2 mg naloxone was injected
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hr after last morphine injection
Fig. 5. Time course of appearance of withdrawal syndrome and the effect
acupuncture with electrical stimulation on it. Rats were addicted
by the 8-week schedule and were observed 13hr after the last
morphine injection, G— 0 without AES treatment, O O Qr with
AES treatment. Wet-dog shakes were counted for 15 min every 2
hr for 2 days.
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1.2.2. Results
As indicated in Fig. 6, naloxone injection increased the
withdrawal score significantly. Compared with the average score
obtained before naloxone injection, an increase of up to 70% was
observed.
As indicated in Fig. 7, AES was effective in suppressing
natural withdrawal. However, after the injection of naloxone,
the total score for withdrawal synptoms increased significantly
beyond that obtained before AES treatment. Apparently, under the
conditions used, AES was only effective against natural but not
naloxone-precipitated withdrawal.
II. Biochemical Studies
II.1. Effect of AES on plasma cAMP levels during natural withdrawal
II.1.1. Method
Rats were divided into two groups, one of which was rendered
dependent on morphine according to the 8-week schedule while the
other group was kept in the same conditions as the addicted group.
After 8 weeks of addiction period, rats were divided into groups
as followed.
(1) R :Normal rats without any drug or AES treatment.
(2) RA:Normal rats treated with AES for 60 min before
decapitation.
(3) RM:Chronic addicted rats, decapitated 14-16 hr after
the last morphine injection.
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Fig. 6. Addicted rats (Schedule 1) were observed 14 hr after the last
morphine injection for 2 successive 30 min periods (scores
were recorded every 5 min). Then they were injected with 0.2
mg naloxone and observed for a further 30 min. (naloxone-





Baseline AES-treated AES+ 0.2 mg naloxone.
n= 6
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Fig. 7. Addicted rats (Schedule 1) were observed 14 hr after the last
morphine injection for 30 min (scores were recorded every 5
min interval). Then AES was applied for 30 min. They were
inected with 0.2 mg naloxone and were observed for a further
30 min period. Only wet-dog shakes were counted. (AES-
treated vs baseline 0.1p0.05).
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14-16 hr after the last morphine injection. Rats
were decapitated at the end of the treatment.
(5) EM,:Chronic addicted rats received an additional dose
4
of morphine and was decapitated 4 hr afterwards.
All rats were removed to the laboratory after the last
morphine injection for overnight stabilization. Needles were
inserted to those rats which would receive AES treatment. Only
water was given ad ti-bitum without food. Next morning after the
treatment rats were decapitated. During this step, special
precautions were taken so as not to arouse the animals. Blood
was collected in heparinized plastic tubes immersed in ice-bath.
Plasma was separated from the blood cells and aliquoted as
quickly as possible. Two volumes of absolute ethanol was added
to the plasma samples to stop the degradation of cyclic nucleo¬
tides as well as for extraction. Assay of plasma cAMP was usually
done on the same day or the day after the sample was obtained.
This experiment was repeated three times.
II.1.2. Results
Compared with non-addicted rats, the average plasma cAMP
level of chronically addict rats was significantly lower (R vs
EM, Fig. 8). On the other hand, the plasma cAMP level of addicted
rats raised signicantly during withdrawal (RM. vs RM).
There is no significant difference in plasma cAMP level
between withdrawing rats (RM) and withdrawing rats treated witb
AES (RMA). Similar result was also obtained from normal rats,
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4
Fig. 8. Effect of AES on plasma cAMP levels during natural
withdrawal. Normal rats and addicted rats (Schedule 1)
were divided into groups and treated as followed:
(1) R: normal rats; (2) RA: normal treated with AES for
60 min, (3) RM: addicted rats decapitated 14-16 hr
after the last morphine injection; (4) RMA: addicted
rats primes with AES for 60 min and decapitated 14-16
hr after the last morphine dose; (5) RM,: addicted rats
4
decapitated 4 hr after morphine injection. Rats were
decapitated and trunk blood collected in heparinized tubes
Plasma cAMP were extracted by ethanol and determined by
radioassay as described in Methods.• (p0.05).
SEM
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significant increase of cAMP level, in both situations described
above, there was, nevertheless, a slight increase of cAMP level
after treatment.
II.2. Effect of AES on plasma cAMP level during naloxone-
precipitated withdrawal
As indicated in our previous experiment, plasma cAMP level
decreases during addiction and rises during withdrawal. AES
significantly attenuates the withdrawal symptoms, however it had
no significant effect on the plasma cAMP during natural withdrawal.
Under this condition the withdrawal symptoms may not be so severe
that the plasma cAMP was not high enough to subjected to regula¬
tion by AES. In order to ressolve this question, naloxone was used
to precipitate the withdrawal symptoms.
Clinically it was observed that subjects addicted for a long
time is best stablized by a decreasing dose of methadone before
treatment with AES. In view of this, rats used in the following
experiment were addicted for 2 weeks instead of 8 weeks. Moreover,
in orienting experiments a dose of 0.2 mgKg of naloxone was
found to be most suitable for inducing AES suppressable withdrawal.
Hence this dose was used in the following experiments.
II.2.1. Method
Addicted rats (2-week schedule) were divided into 2 groups
and normal rats were divided into 3 groups and processed as
described in section I.1.1.
(1) R: Normal rats without any drug treatment.
43
(2) RN: Normal rats were injected with 0.2 mg naloxone and
decapitated 30 min. afterwards.
(3) RNA: Normal rats were primed with AES for 60 min. Then
they were injected with 0.2 ragKg naloxone and
decapitated 15 min. afterwards.
(4) N: Addicted rats, 14-16 hr after the last morphine
injection, they were injected with 0,2 mgEg of
naloxone and withdrawal symptoms observed for 15
min. Then they were decapitated.
(5) AN: Addicted rats, 14-16 hr after the last morphine injection,
were primed with AES for 60 min. Then 0.2 mgKg of
naloxone was injected and withdrawal symptoms were
observed for 15 min. Then they were decapitated while
AES was still maintained all the time.
II.2.2. Results and Discussions
Compared with natural withdrawal, the symptoms observed
in naloxone-precipitated withdrawal were much more severe.
The plasma cAMP level in normal rats was not significantly
affected by injection of naloxone (R vs RN) or by naloxone plus
AES (R vs RNA) (Fig. 9).
The plasma cAMP level was again significantly raised during
naloxone precipitated withdrawal (N vs R, 0„lp0.05). Under
the conditions used, AES significantly lowered the withdrawal
score (N vs AN, 0.01p0.001). In addition, the plasma cAMP
level was also lowered by about 20% after treatment, although
the level of significance was not high (0„2p0.1).
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When the plasma cAMP level of individual rat is plotted
against their behavioral score, there is a positive correlation
(Fig. 10). In general, higher levels of cAMP is associated with
higher scores. Moreover, the majority of the rats treated with
AES tends to reside in the lower left region of the graph while
half of those non-AES treated rats resides in the upper right
region. These results strongly suggests that plasma cAMP level
is intimately related to the intensity of withdrawal and that
AES is effective in suppressing both withdrawal behavior and plasma
cAMP level under the conditions used in our exDeriment.
Although the origin of basal cAMP in the body fluid is
uncertain, our results clearly indicate that morphine can signi¬
ficantly lower plasma cAMP level (KM, vs R, Fig. 8). The plasma.
cAMP level increases during withdrawal and these increases are
proportional to the degree of withdrawal. One source of plasma
cAMP may result from hormonal stimulation, (Jose and Rickenberg,
1971). Since addicted rats have a very low plasma ACTH and that
ACTH can increase plasma cAMP level (Broadus et at._, 1971), the
lower level of plasma cAMP in the addicted rats may be due to a
lack of ACTH to stimulate the AC in the adrenal gland. At the
same time the lower level of cAMP in the plasma may reflect a
possible inhibition of neural activity as a result of drug action.
Nominal support for this idea comes from the fact that cAMP is
believed to be involved in modulating neural functions (Nathanson,
1977); and that opiates and opiate peptides have been shown to
inhibit various neurotransmitter-sensitive adenylate cyclase
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systems, (Sharma et al. 3 1975b; Tsang et al. 1978; Motomasu et
cel., 1977); and that intracellular cAMP can be extruded into the
extracellular fluid by certain neural tissues (Nathanson, 1977).
By similar reasoning, rats under withdrawal have a very high ACTH
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Fig. 9. Effect of AES on plasma cAMP level of morphine-addicted
rats during naloxone-precipitated withdrawal. (A) Rats
were divided into groups as followed: (1) R: normal rats
(2) RN: normal decapitated 30 min after injection of 0.2
mg/Kg naloxone, (3) RAN: normal primed with AES for 60 min
and then injected with 0.2 mg/Kg naloxone and decapitated
30 min afterwards (4) N: addicted rats injected with 0.2
mg/Kg naloxone and observed for 15 min. before decapitation,
and (5) AN: addicted rats were primed with AES for 60 min,
then injected with 0.2 mg/Kg naloxone and observed for 15
min before decapitation. Plasma cAMP were extracted and
determined as described in section I.1.1. (R vs N,
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Fig. 10. Correlation between plasma cAMP and withdrawal scores.
• N: addicted rats injected with 0.2 ragKg naloxone and
observed for 15 rriin before decapitation.
iVAN: addicted rats we re primed wit h A E S f o r 6 0 min, th e n
injected with 0.2 mgKg naloxone and observed for 15 min
before decapitation. Plasma cAMP were extracted and
determined as described in Methods.
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Studies on Mice
Since rats were in general quite difficult to handle in large
number, our previous experiments could only be carried out with
a small number of animals at a time. One major problem involved
in this type of experimental design is that it is tedious and can
introduce highly variable results when the data obtained in one
day has to be pooled with those obtained in another. In view of
these drawbacks our experiments were repeated using mice instead
of rats. The choice of mice for our experiment is because they
can be handled in larger number and the withdrawal behavior, such
as jumping, is much easier to observe. In addition, the size of
a mouse brain is much smaller than that of a rat and fixation by
quick freeze in liquid nitrogen for the cAMP assay could be
performed more effectively.
Two weeks before the actual experiment mice were addicted and
scanned for their ability to jump when challenged with an injec¬
tion' of naloxone. Only those which showed withdrawal jumping were
selected. Mice were chosen this way not only because of their
ability to express quantitizable withdrawal symptoms but also
because they are more susceptible to morphine induced biochemical
changes (Iwamoto et at1973; Way Bhougava, 1976).
I. Behavioral studies
Addicted mice were injected with naloxone intraperitoneally
one day after the second morphine pellet implantation. In general
the pellets were not removed during the experiment. Mice were
placed in transparent plastic boxes without top for observation.
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Four withdrawal symptoms were chosen for quantitiative presentation
(Maggiolo Huidobro, 1961). They were jumping (uncontrollable
and often repeated), body shake, diarrhea, and abnormal posturing
(sniffing and digging with head turning left and right slowly,
constriction of abdomen). The frequency of occurance of the
above symptoms were recorded on standard score sheet. Whenever
a sign lasted for more than 15 sec another score was given. Normal
mice injected with naloxone did not show any withdrawal signs and
symptoms.
I.1. Effect of naloxone dosage on withdrawal induction and the
effect of AES
1.1,1. Method
Mice were rendered dependent on morphine by pellet implantation.
Twenty four hours after the implantation of the second pellet
addicted mice were divided into 2 groups. One group was treated
with AES for 60 min before the injection of naloxone and the other
received naloxone only. The above 2 groups were further divided
into 3 groups; each group received a different dose of naloxone
(5, 10 or 20 mgKg). All mice were observed for 15 min after the
injection of naloxone.
1.1.2. Results
Naloxone at the three concentrations used, viz., 5, 10 and
20 mgKg, all induced wihtdrawal signs and symptoms in morphine-
addicted mice (Fig. 11). The highest withdrawal scores were
obtained when naloxone was injected at a dose of 10 mgKg. Since
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Fig. 11. Effect of naloxone dosage on morphine withdrawal
behavorial score and the effect of AES.
Mice were addicted by pellet implantation.
Twenty-four hours after the implantation of
the second morphine pellet, they were treated
with—, and without O—© AES for 60
min. At the end of the 60 min, naloxone was
injected to induce withdrawal. The withdrawal
scores were counted for 15 min.
(AES vs non-AES at naloxone dose of 10 mgKg,
P0.05)
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all the subsequent studies.
AES suppressed the withdrawal score precipitated at all the
3 concentrations of naloxone used. Compared with the non-treated
groups, statistical significance of difference was found only
when the withdrawal was precipitated at 10 mgKg naloxone.
II. Biochemical studies
II.1. Effect of AES on cAMP levels during naloxone precipitated
morphine withdrawal
II.1.1. Method
Mice were rendered dependent on morphine by pellet implanta¬
tion. In the third morning mice were divided into 2 groups. Some
normal mice were used as controls.
(1) R: Normal mice without drug or AES treatment.
(2) N: Addicted mice, were injected with 10 mgKg (0.25 mg
0.2 ml, i.p.) naloxone and were observed for 15 min
before decapitation.
(3) AN: Addicted mice, were treated with AES for 60 min, and
then were injected 10 mgKg naloxone and observed
for 15 min before decapitation.
The average voltage used for AES was 0.5 V. Mice were
decapitated and the heads immersed immediately in liquid nitrogen.
Brain cAMP was extracted and assayed within 2 days as described
in Methods.
II.1.2. Results and Discussion
Under the conditions described above AES significantly
lowered both the jumping response and the withdrawal score (Fig
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12), (N vs. AN; 0.Qlp0.001). Compared with the normal (N),
a slight increase of mean cAMP level was observed in the brain
of mice under withdrawal (R vs. N AN; 0.3p0.2). There is
no significant difference between the AES-treated (AN) and the
non-AES-treated (N) groups. We have attempted as in Section II.
2.2. to correlate the withdrawal scores with the brain cAMP
level, but the values were scattered so widely that no correlation
could be found.
The failure to find an association between the fall of brain
cAMP level and the reduction of withdrawal symptoms may be explained
bv:
1) The change of cAMP is localized in certain regions. Unless
an extreme large change in cAMP level occurs, the whole
brain cAMP level is not likely to change significantly.
Regional alternations of the compound, would be much more
informative.
2) The method of fixation is not quick enough to fix the post¬
mortem increase of cAMP level. The high base line value























Fig. 12. Effect of AES on brain cAlP level in naloxone-induced
withdrawal of morphine addicted mice.. Mice were addicted by-
pellet implantation method. They were divided into groups and
treated as .followed: (1) R: normal mice; (2) N: addicted mice
injected with 10 mgKg naloxone and observed 15 min before
decapitation, and (3) AN: addicted mice primed with AES for 60
min and then inject with 10 mgKg naloxone and observed for 15
min before decapitation. Withdrawal score were recorded. Brain
cAMP were extracted and determined as described in iethods.
tHc(N vs AN, p 0.01)
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Studies on Xanthines and dibutyl-cAMP on the treatment of morphine
withdrawal by AES
It is widely accepted that changes in cAMP levels and
cyclase activity will affect the development of tolerance to and
physical dependence on morphine. From the results in our previous
experiments it seems that a reduction of cAMP level may play a
role in the action of AES on the suppression of withdrawal syndrome
3-isobutyl-methyIxanthine (IBMX) and 1s3-dimethylxanthine (theophyl¬
line), drugs which are known to inhibit phosphodiesterase and
elevate intracellular cAMP level and dibutyl-cAMP (DBcAMP), a
cAMP analogue which enters cells more readily than cAMP, were
administrated to see whether an artificially induced rise in cAMP
will affect the suppression of withdrawal symptoms by AES.
I. Effect of IBMX on AES suppression of withdrawal syndrome in
rats
1.1. Method
Twenty-one rats were rendered addicted according to 2-week
schedule and were processed as described in Rats: section I.1.1.
They were moved to the laboratory after the last morphine in¬
jection for overnight stabilization. Needles were inserted and
only water was given. The rats were divided into 4 groups.
(1) N: Addicted rats injected with 0.5 ml 10% EtOH saline
kept at 37°C subcutaneously near the tigh. After
45 min rats were injected with 0.2 mgKg (0.05 mg
0.2 ml) naloxone (i.p.) and observed for 15 min
before decapitation.
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(2) AN: Addicted rats injected with 0.5 ml 10% EtOH saline
(s.c.) and AES was applied. After 45 min they were
injected with 0.2 mgKg naloxone (i.p.) and observed
for 15 min before decapitation.
(3) TN: Addicted rats injected with 10 mgKg IBM! (2.5 mg0.5
ml; s.c.) in 10% EtOH saline kept at 37°C. After
45 min they were injected with 0.2 mgKg naloxone and
observed for 15 min before decapitation.
(4) ATN: Addicted rats injected with 10 mgKg IBMX (s.c.).
After treatments with AES for 45 min, they were
injected with 0.2 mgKg naloxone and observed for
15 min before decapitation.
Blood was collected in heparinized plastic tubes and immersed
immediately in an ice bath. Plasma cAMP level was assayed within
two davs.
II.2. Results and discussion
As previously observed AES significantly lowered the withdrawal
score (N vs AN; 0.1p0.05; Fig. 13). Again there was a 12%.decrease
in plasma cAMP level though it was not statistically significant,
(0.7p0.6).
IBMX administration raised the plasma cAMP tremendously
(seven fold increase vs normal) in addition to the withdrawal
behavioral score (TN vs N). Another severe withdrawal symptom,
jumping, which was never seen in rats in the previous experiments
was observed. IBMX also enhanced several other symptoms, including


















Fig. 13. Effect of IBMX on AES suppression of withdrawal symptoms in mor¬
phine addicted rats. Rats were addicted by the 2-week schedule
and divided into 4 groups and treated as followed: (1) N:
addicted rat injected with saline (s.c.) and after 45 min 0.2
mgKg naloxone (i.p.), (2) AN: addicted rats injected with saline
(s.c.) treated with AES for 45 min and then injected with 0.2 mg
Kg naloxone, (3) TN: addicted rats injected with 2.5 mg IBMX (s.c.)
and after 45 min 0.2 mgKg naloxone and (4) ATN: addicted rats
injected with 2.5 mg IBMX (s.c.) and treated with AES for 45 min
and then injected with 0.2 mgKg naloxone. All animals were
observed for 15 min after the injection of naloxone. All animals
were observed for 15 min after the injection of naloxone and then
decapitated. Plasma cAMP were extracted and determined as described
in Rat: section I.1.1. Plasma cAMP level: (N vs TN; p0.05)
(AN vs ATN; p0.001). Withdrawal Scores: N (N vs AN;
0.1p0.05), AN (AN vs ATN; 0.1p0.05)
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There was no significant difference in the withdrawal score and
the plasma cAMP between the withdrawing rats injected with IBMX
(TN) and the withdrawing rats treated with AES and IBMX (ATN).
This suggested that the suppressive effect by AES on withdrawal
symptoms was completely cancelled by pretreatment with IBMX.
II. Effect of theophylline on AES suppression of withdrawal
Qpnrp in rni pp
II.1. Method
Mice were rendered dependent on morphine by pellet implanta¬







R: Normal mice without drug or AES treatment.
RT: Normal mice were injected with 35 mgKg theophylline
in saline (1 mg0.2 ml, i.p.) and were decapitated
45 min afterwards.
N: Addicted mice were injected with 10 mgKg naloxone
(i.p.) and were observed for 15 min before decapitation
TN: Addicted mice were injected with 35 mgKg theophylline
(i.p.) and were observed for 30 min. Then they were
injected with 10 mgKg naloxone and were observed for
a further 15 min before decapitation.
ATN: Addicted mice were primed with AES for 60 min. 35
mgKg theophylline (i.p.) was injected and the mice
were observed for 30 min. Then they were injected
with 10 mgKg naloxone and were observed for a
further 15 min before decapitation. AES was main¬
tained all the way until decapitation.
58
Brain cAMP were extracted and determined described in
Methods within two days.
II.2. Results and discussion
Comparing with normal mice, after the injection of theophyl¬
line, most of the addicted mice were slightly more active; only
diarrhea and no other withdrawal symptoms were observed in the
first 30 min before naloxone was injected.
After the injection of naloxone, the withdrawal score was
higher in mice treated with theophylline (TN) than those without
(N). However, this difference is not statistically significant
(0.3p0.2). Mice treated with AES plus theophylline
(ATN) showed higher withdrawal score than both of the control
groups (N TN), but the difference between ATN and TN was not
statistically significant (0.1p0.05) (Fig. 14).
The plasma and the whole brain cAMP level were not statis¬
tically different from each other amongst all of the groups, but
the mean brain cAMP levels in the theophylline treated mice were
generally slightly higher than those without theophylline treatment
These findings indicates that under these conditions of
treatment, theophylline not only cancelled the suppressive effect
on withdrawal symptoms, but also seemed to reverse the effect of
AES in addition to its action on increasing level of cAMP.
The results of the previous two experiment showed that
the degree of withdrawal of morphine addicted rats and mice was





















R RT N TN ATN
Fig. 14. Effect of theophylline on AES suppression of withdrawal symptoms
in morphine addicted mice. Mice were addicted by pellet implan-
tation and divided into groups and treated as followed: (1) R:
norami mice, (2) RT: normal mice injected with 1 mg theophylline,
(3) N: addicted mice injected with 10 mgKg naloxone and observed
for 15 min before decapitation, (4) TN: addicted mice injected
with 1 mg theophylline (i.p.), observed for 30 min, injected with
10 mgKg naloxone and observe for a further 15 min before decapi-
tation, and (5) ATN: addicted mice primed with-AES for 60 min,
injected with 1 mg theophylline (i.p.), observed for 30 min, injecte
with 10 mgKg naloxone and observed for another 15 min before
decapitation. Brain cAMP was extracted and determined as des-
cribed in the method. (N vs ATN. 0.1d0.051
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This synergical effect suggests that naloxone and PDE inhibitors
may act at different parts of a related mechanism, which is also
common to or at least crossed over at some point with the mechanism
of AES in the suppression of withdrawal syndrome. The antagonism
of AESfs suppressive effect on withdrawal by PDE inhibitors would
suggest that one of the underlying mechanism of AES may be asso¬
ciated with the cAMP-PDE system. Injection of cAMP into specific
regions of the brain would undoubtedly provide additional data to
map out the site of action of AES.
III. Effect of DBcAMP on AES suppression of withdrawal syndrome
III.l. Method
Twenty-four mice were rendered addicted to morphine by





N: Addicted mice were injected with 2 yl 0.9% saline
intracereborventricularly (i.e.) with Hamilton
Syringe (27G) according to Cox (1972) and were
observed for 15 min. Afterwards they were injected
with 10 mgKg naloxone (i.p.) and observed for
another 15 min.
AN: Addicted mice primed with AES for 60 min. They were
injected with 2 yl 0.9% saline (i.e.) and were
observed for 15 min. Afterwards they were injected
with 10 mgKg naloxone and were observed for another
15 min.
PN: Addicted mice were injected with 10 yg DBcAMP in
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(4) APN:
2 yl 0.9% saline (i.e.) and were observed for 15 min.
Then they were injected with 10 mgKg naloxone (i.p.)
and were observed for another 15 min.
Addicted mice primed with AES for 60 min. They
were injected with 10 yg DBcAMP in 2 yl 0.9% saline
(i.e.) and were observed for 15 min. Then they
were injected with 10 mgKg naloxone (i.p.) and were
observed for another 15 min.
III.2. Results and Discussion
After the injection of saline or DBcAMP into the brain, the
mice were calm and reluctant to move but they regained normal
activities within half a minute. No withdrawal score was recorded in
the first 15 min of observation before naloxone was injected.
Compared with our previous results, AES was only marginally
effective in suppressing withdrawal induced by naloxone (N vs
AN: 0.1p0.05, Fig. 15) DBcAMP injected into the brain was found
to significantly antagonize the suppressive effect of AES on
withdrawal (APN vs AN). The degree of withdrawal observed in
the DBcAMP treated mice (PN) or the DBcAMP plus AES treated mice
(APN) were significantly greater than that of the AES treated mice
(AN). Furthermore the degree of withdrawal of mice injected with
DBcAMP (PN and APN) was also greater than those injected with
saline (N).
The present finding further supports the idea that a rise in
brain cAMP level would lead to antagonization of the suppressive
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ELg.15. Effect of DBcAtP on AES suppression of withdrawal symptoms. Mice
were addicted by pellet implantation and divided into groups and
treated as followed: (1) Nraddicted mice injected with 2 yl saline
(i.e.), observed 15 min, then injected with 10 mgKg naloxone and
observed for another 15 min, (2) AN: addicted mice treated with
AES for 60 min, injected with 2 yl saline (i.e.), observed 15 min,
then injected with 10 mgKg naloxone and observed for another 15
min, (3) PN: addicted mice injected with 10 yg DBcAMP in 2 yl saline
(i.e.), observed for 15 min, then injected with 10 mgKg naloxone
and observe for another 15 min, and (4) APN: addicted mice treated
with AES for 60 min, injected with 10 yg DBcAMP in 2 yl saline and
observed for 15 min, then injected with 10 mgKg naloxone and observed
for another 15 min. (N vs AN, 0.1p0.05) (AN vs APN, P=0.05).
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GENERAL DISCUSSION
Our experimental results confirmed the clinical observa¬
tions of Wen (1973, 1977). Omura (1976) and (1976) that
AES on the conchae suppresses withdrawal symptoms in morphine-
addicted human. We observed a rise of plasma and brain cMP
levels during withdrawal in dependent rats and mice. We also
found that plasma cAMP level was lowered by AES treatment during
naloxone precipitated withdrawal. thfortunately this reduction
was not statistically significant and the cause may be due to
large individual differences and to inherent insensitivity of
plasma cMP level to reflect changes occuring at the tissue
level.
In contrast to rats under withdrawal,AES slightly increases
the mean plasma cAl P level of normal rats as well as addicted
rats (still on drug). A similar pattern of changes was observed
in plasma ACTH (Choy et at.. 1978; Tsang, 1978).
In addition to our experience, the above dual regulatory
effect of AES on normal and abnormal (e.g., in the addicted state
of our animals) physiological states have been noted by a number
of workers (O'Connor Bensky, 1975; Omura, 1976). In fact our
finding on the effect of AES on biochemical changes agree well
with previous clinical observations (Ho et al. 1977; Wen et al.
19 78a. 19 78b: Wone. 19 77).
Our finding supports the proposal that an increase in cAIP
level induced by either oral, i.p., i.v. or i.e. administration
of the cAIP PDE inhibitors enhances the degree of withdrawal
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(Ho et al.y 1972; Collier et at., 1975). The enhancement by i.e.
injection would suggest the increase in cMP is most important
in the brain, particularly around the third ventricle and the
aqueduct.
Collier (1977) and Sharma et al. (1975b) suggested that
morphine may exert its agonist action by inhibiting adenylate
cyclase activity in the morphine-sensitive neurons. Sharma's
dual regulation model would infer that the morphine withdrawal
syndrome may result from an increase in cAlP level of the morphine-
sensitive neurons. Our finding that the brain cAlP seemed to
increase during naloxone-precipitated withdrawal is compatible
with this proposition and is in accordance withMahta and Johnson's
(1975) observation that the brain cAlP increased during naloxone-
precipitated withdrawal and the magnitude of increase was pro¬
portional to the intensity of the withdrawal syndrome.
Based on a survey of the current literature and the results
obtained in the present study, the action of AES in suppressing
withdrawal symptoms may be related to the secretion of endogenous
opiate peptides (Mayer and Price, 19 76;. Omura, 1977; Marx, 1978).
These peptides, particularly the endorphines, can replace morphine
and compete with naloxone for the opiate receptors. In addition
they have shown to inhibit adenylate cyclase activity. It is
possible that by inhibiting adenylate cyclase in the morphine-sensitive
neurones they can attenuate the withdrawal syndrome.
Our finding that the administration of PDE inhibitors or
DBcAtP can reverse the suppressive action of AES on withdrawal
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symptoms supports the idea that the action of AES may be mediated
by an indirect mechanism through changes of tissue cMP level.
If we assume that an increase in intracellular cMP level can
bypass the inhibitory effect of the endorphines on the AC system,
the cancellation of AES's effect by PDE inhibitors and DBcAlP
can then be explained.
A strong support for the active role played by cMP in
withdrawal comes from the observation that quasimorphine abs-
tinense syndrome (Q4AS) can be induced in normal rats by the
administration of PDE inhibitors. This QfAS is enhanced by a
small dose of naloxone (Collier et al.j 1975). Since naloxone
and PDE inhibitor act synergically, each probably acts at a
different part of a related mechanism. Moreover, since IMX
acts in the absence naloxone, it may exert its effect on a cAMP
system which lies in the same chain of biochemical events
associated with naloxone precipipated withdrawal (e.g. cAIP or
PDE inhibitors may increase intracellular cAIP level and bypass
the inhibition of AC by endogenous opiate peptides; naloxone
antagonizes the opiate peptide inhibitory effect of AC activity
and enhance the cA4P effect further). The mechanism also
explains our results that the true morphine abstinence syndrome
was enhanced by cAIP and PDE inhibitors.
Besides, AES may exert its action directly on the neural
function system involved in the expression of withdrawal
syndrome (as suggested by Collier, 1972) through some as yet
unknown mechanims (e.g. by influencing their electrophysiology
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and thus modulating the activities of these systems). If these
systems are also modulated by cAlP such as the monoaminergic
pathways, then administration of cAlP will directly affect
these systems thus enhances the degree of withdrawal and cancells
the effect of AES.
In conclusion, our observations suggest that morphine
addiction and abstinence are regulated by neural functional sys-
tmes that are directly or indirectly modulated by cAMP and that
suppressive action of AES on withdrawal symptoms can be anta-
gonised by an elevated level of this cyclic nucleotide.
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